2010
DOI: 10.1038/npp.2010.20
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Lipid Raft Integrity on 5-HT3 Receptor Function and its Modulation by Antidepressants

Abstract: Because of the biochemical colocalization of the 5-HT 3 receptor and antidepressants within raft-like domains and their antagonistic effects at this ligand-gated ion channel, we investigated the impact of lipid raft integrity for 5-HT 3 receptor function and its modulation by antidepressants. Treatment with methyl-b-cyclodextrine (MbCD) markedly reduced membrane cholesterol levels and caused a more diffuse membrane distribution of the lipid raft marker protein flotillin-1 indicating lipid raft impairment. Both… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

3
36
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 38 publications
(39 citation statements)
references
References 46 publications
3
36
0
Order By: Relevance
“…More recently developed ADs were designed to specifically impede the activity of neurotransmitter transporters, and are thus called selective serotonin re-uptake inhibitors (SSRIs) or selective serotonin/noradrenalin re-uptake inhibitors (SSNRIs). However, mounting evidence suggests the existence of various additional targets for both, TCAs and SSRIs/NRIs, which may be either supportive for the therapeutic effects, or at the contrary, trigger adverse events (Carvalho et al, 2010;Herr et al, 2003;Nothdurfter et al, 2010;Perisic et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…More recently developed ADs were designed to specifically impede the activity of neurotransmitter transporters, and are thus called selective serotonin re-uptake inhibitors (SSRIs) or selective serotonin/noradrenalin re-uptake inhibitors (SSNRIs). However, mounting evidence suggests the existence of various additional targets for both, TCAs and SSRIs/NRIs, which may be either supportive for the therapeutic effects, or at the contrary, trigger adverse events (Carvalho et al, 2010;Herr et al, 2003;Nothdurfter et al, 2010;Perisic et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…The antagonistic potency against the peak amplitude and charge and the Fluox-induced acceleration of receptor desensitization could be shown both under control conditions and after MßCD induced cholesterol depletion (O Fig. 5b, right panel [24]). Immunocytochemistry revealed a more diffuse distribution and signal enhancement of the lipid raft marker protein flotillin-1 upon cholesterol depletion by MßCD or the hydroxyl-methylglutaryl-coenzyme A reductase inhibitor simvastatin (Sim), thereby showing lipid raft impairment (o Fig.…”
mentioning
confidence: 92%
“…la[11] and oFig. 5a[24]) When lipid raft integrity was impaired by means of methyl-ß-cyclodextrine (MßCD) induced cholesterol depletion, the DMI induced inhibition and kinetic changes were still retained, although pretreatment with MßCD markedly diminished baseline 5-HT3 receptor currents (oFig. 5a, right panel[24]).…”
mentioning
confidence: 96%
See 2 more Smart Citations